Prelude Capital Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-24,485
Closed -$430K 2119
2021
Q3
$430K Buy
+24,485
New +$430K 0.01% 726
2017
Q3
Sell
-29,700
Closed -$131K 1858
2017
Q2
$131K Buy
29,700
+6,200
+26% +$27.3K 0.01% 639
2017
Q1
$145K Hold
23,500
0.01% 628
2016
Q4
$133K Buy
23,500
+23,100
+5,775% +$131K 0.02% 700
2016
Q3
$6K Buy
400
+200
+100% +$3K ﹤0.01% 1409
2016
Q2
$2K Buy
+200
New +$2K ﹤0.01% 1461